These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 37682293)

  • 1. The choroidal nervous system: a link between mineralocorticoid receptor and pachychoroid.
    Leclercq B; Weiner A; Zola M; Mejlacowicz D; Lassiaz P; Jonet L; Gélizé E; Perrot J; Viengchareun S; Zhao M; Behar-Cohen F
    Acta Neuropathol; 2023 Nov; 146(5):747-766. PubMed ID: 37682293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the choroidal features in pachychoroid spectrum diseases by optical coherence tomography and optical coherence tomography angiography.
    Demirel S; Değirmenci MFK; Batıoğlu F; Özmert E
    Eur J Ophthalmol; 2021 Jan; 31(1):184-193. PubMed ID: 31684767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy.
    Zhao M; Célérier I; Bousquet E; Jeanny JC; Jonet L; Savoldelli M; Offret O; Curan A; Farman N; Jaisser F; Behar-Cohen F
    J Clin Invest; 2012 Jul; 122(7):2672-9. PubMed ID: 22684104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EN FACE IMAGING OF PACHYCHOROID SPECTRUM DISORDERS WITH SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY.
    Dansingani KK; Balaratnasingam C; Naysan J; Freund KB
    Retina; 2016 Mar; 36(3):499-516. PubMed ID: 26335436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic Effects of Mineralocorticoid Pathway Activation in Retinal Pigment Epithelium.
    Canonica J; Zhao M; Favez T; Gelizé E; Jonet L; Kowalczuk L; Guegan J; Le Menuet D; Viengchareun S; Lombès M; Pussard E; Arsenijevic Y; Behar-Cohen F
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Systemic Dexamethasone Regulates the Mineralocorticoid/Glucocorticoid Pathways Balance in Rat Ocular Tissues.
    Zola M; Mejlachowicz D; Gregorio R; Naud MC; Jaisser F; Zhao M; Behar-Cohen F
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging-based Assessment of Choriocapillaris: A Comprehensive Review.
    Singh RB; Perepelkina T; Testi I; Young BK; Mirza T; Invernizzi A; Biswas J; Agarwal A
    Semin Ophthalmol; 2023 Jul; 38(5):405-426. PubMed ID: 35982638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pachychoroid Spectrum Disease: Underlying Pathology, Classification, and Phenotypes.
    Hua R; Duan J; Zhang M
    Curr Eye Res; 2021 Oct; 46(10):1437-1448. PubMed ID: 34114902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pachychoroid spectrum disease.
    Borooah S; Sim PY; Phatak S; Moraes G; Wu CY; Cheung CMG; Pal B; Bujarborua D
    Acta Ophthalmol; 2021 Sep; 99(6):e806-e822. PubMed ID: 33258304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathomechanisms in central serous chorioretinopathy: A recent update.
    Zarnegar A; Ong J; Matsyaraja T; Arora S; Chhablani J
    Int J Retina Vitreous; 2023 Jan; 9(1):3. PubMed ID: 36670451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new insight into pachychoroid diseases: Remodeling of choroidal vasculature.
    Kishi S; Matsumoto H
    Graefes Arch Clin Exp Ophthalmol; 2022 Nov; 260(11):3405-3417. PubMed ID: 35575932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of pachychoroid diseases.
    Akkaya S
    Int Ophthalmol; 2018 Oct; 38(5):2239-2246. PubMed ID: 28766279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pachychoroid Disease].
    Faatz H; Lommatzsch A
    Klin Monbl Augenheilkd; 2023 Feb; 240(2):218-232. PubMed ID: 36395810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choroidal congestion mouse model: Could it serve as a pachychoroid model?
    Matsumoto H; Mukai R; Hoshino J; Oda M; Matsuzaki T; Ishizaki Y; Shibasaki K; Akiyama H
    PLoS One; 2021; 16(1):e0246115. PubMed ID: 33507997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Research progress of pachychoroid disease spectrum].
    Li LX; Zhang P
    Zhonghua Yan Ke Za Zhi; 2023 Jan; 59(1):68-72. PubMed ID: 36631062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Stromal and Luminal Areas of the Choroid in Pachychoroid Diseases: Insights Into the Pathophysiology of Pachychoroid Diseases.
    Lee M; Lee H; Kim HC; Chung H
    Invest Ophthalmol Vis Sci; 2018 Oct; 59(12):4896-4908. PubMed ID: 30347084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mineralocorticoid antagonists in the treatment of central serous chorioetinopathy: Review of the pre-clinical and clinical evidence.
    Bousquet E; Zhao M; Daruich A; Behar-Cohen F
    Exp Eye Res; 2019 Oct; 187():107754. PubMed ID: 31401003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vortex Vein Anastomosis at the Watershed in Pachychoroid Spectrum Diseases.
    Matsumoto H; Hoshino J; Mukai R; Nakamura K; Kikuchi Y; Kishi S; Akiyama H
    Ophthalmol Retina; 2020 Sep; 4(9):938-945. PubMed ID: 32651158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choriocapillaris flow features and choroidal vasculature in the fellow eyes of patients with acute central serous chorioretinopathy.
    Yun C; Huh J; Ahn SM; Lee B; Kim JT; Hwang SY; Kim SW; Oh J
    Graefes Arch Clin Exp Ophthalmol; 2019 Jan; 257(1):57-70. PubMed ID: 30397792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional segmentation and depth-encoded visualization of choroidal vasculature using swept-source optical coherence tomography.
    Zhou H; Bacci T; Freund KB; Wang RK
    Exp Biol Med (Maywood); 2021 Oct; 246(20):2238-2245. PubMed ID: 34259053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.